核酸
化学
结核分枝杆菌
清脆的
DNA
核酸检测
异烟肼
计算生物学
质粒
核糖核酸
抗药性
反式激活crRNA
杂交探针
复式(建筑)
脱氧核酶
数字聚合酶链反应
解旋酶
DNA测序
肺结核
引物酶
分子生物学
核酸热力学
突变
肽核酸
抗生素耐药性
突变体
临床诊断
病毒学
痰
作者
Xinyi Liao,Junhong Chen,Yunzhu Wan,Wenfei Xu,Jianhua Zhou,Yanping Liu,Xuhui Li,Chongguang Yang,Jiasi Wang
标识
DOI:10.1021/acs.analchem.6c02379
摘要
Drug-resistance Tuberculosis (TB) is a major threat to global public health. Simple and precise detection of the mutations associated with drug resistance is still a significant challenge. CRISPR-based nucleic acid detection has emerged as a transformative technology in molecular diagnostics due to its high specificity and programmability. However, the CRISPR-Cas12a system requires a protospacer adjacent motif (PAM) in the target double-stranded DNA (dsDNA) for efficient recognition and activation, which limits its application for detecting single-nucleotide variants (SNVs). To overcome this limitation, we leveraged high-affinity xenonucleic acids (XNAs) to engineer an XNA-CRISPR platform that combines a helicase and sequence-specific XNAs (such as peptide nucleic acid (PNA), locked nucleic acid (LNA), or 2'-modified RNA), to unwind the dsDNA, enabling them to invade and form stable hybrids, thereby displacing a single strand for PAM-independent Cas12a activation. This recognition mechanism, combining XNA hybridization and CRISPR verification, achieves single-base resolution. To bridge the sensitivity gap for clinical application, we integrated this platform with polydisperse droplet digital technology (PddXNA-CRISPR), which significantly enhanced the sensitivity. Clinical sputum samples were detected by using PddXNA-CRISPR for Mycobacterium tuberculosis (MTB) katG Ser315Thr mutation, which showed 90% concordance with sequencing results. This modular, amplification-free platform expands the CRISPR-based diagnostic toolkit and provides a versatile and sensitive approach for detecting critical SNVs.
科研通智能强力驱动
Strongly Powered by AbleSci AI